| Filed | Form | Description | |
|---|---|---|---|
| 8/25/25 | DEF 14A | DEF 14A | → |
| 8/15/25 | PRE 14A | PRE 14A | → |
| 4/24/25 | DEFA14A | DEFA14A | → |
| 4/24/25 | DEF 14A | DEF 14A | → |
| Filed | Form | Description | |
|---|---|---|---|
| 1/14/26 | 4 | 4 | → |
| 1/14/26 | 3 | 3 | → |
| 12/17/25 | 4 | 4 | → |
| 12/17/25 | 4 | 4 | → |
| 12/17/25 | 4 | 4 | → |
| 12/8/25 | 4 | 4 | → |
| ↓ | |||
Fractyl Health is a Burlington, Massachusetts-based healthcare company focused on metabolic diseases like obesity and type 2 diabetes. The company developed Revita, an outpatient endoscopic procedure to modify duodenal dysfunction, and Rejuva, a gene therapy platform in preclinical development to enable the pancreas to produce glucagon-like peptide-1 (GLP-1).